Anthony T. Yachnis

University of Florida — United States

Medicine · Health Sciences

54h-index14.3kcitations238works6.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(63), Cancer, Hypoxia, and Metabolism(17), Neurofibromatosis and Schwannoma Cases(17), Neuroblastoma Research and Treatments(17), Meningioma and schwannoma management(16)

Publications236 total

Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas
PLoS ONE·2026Open Access
Repeat-associated non-AUG translation as a common mechanism for the polyGln ataxias
Cell Reports·2025Open Access
Repeat associated non-AUG translation as a common mechanism for the polyGln ataxias
2025Open Access
Immortalization and Characterization of Schwann Cell Lines Derived from NF1 Associated Cutaneous Neurofibromas
2025· 1 citedOpen Access
<i>CASP8</i> intronic expansion identified by poly-glycine-arginine pathology increases Alzheimer’s disease risk
Proceedings of the National Academy of Sciences·2025· 6 citedOpen Access
A Rare Presentation of Adult Primary Leptomeningeal Medulloblastoma: Case Report
Case Reports in Pathology·2025· 1 citedOpen Access
Cerebrospinal fluid flow extends to peripheral nerves further unifying the nervous system
Science Advances·2024· 37 citedOpen Access
Cerebrospinal Fluid Flow Extends to Peripheral Nerves
2023Open Access
Supplementary Figure S6qc from Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma
2023Open Access
Supplementary Legends_qc from Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma
2023Open Access
Supplementary Figure S2qc from Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma
2023Open Access
Supplementary Figure S2qc from Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma
2023Open Access
Supplementary legend from Anticancer Effects of Niclosamide in Human Glioblastoma
2023Open Access
Supplemental Figure 3 from Anticancer Effects of Niclosamide in Human Glioblastoma
2023Open Access
Supplementary Figure S5qc from Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma
2023Open Access
Supplemental Figure 2 from Anticancer Effects of Niclosamide in Human Glioblastoma
2023Open Access
Supplementary Figure S1qc from Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma
2023Open Access
Supplemental Table 1 from Anticancer Effects of Niclosamide in Human Glioblastoma
2023Open Access
Supplementary Figure S6qc from Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma
2023Open Access
Supplementary Figures S3qc and S4qc from Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma
2023Open Access
page 1 of 12Next →

Frequent Co-authors

Lucy B. Rorke(8), Dennis A. Steindler(5), Tao Zu(4), Laura P.W. Ranum(4), Amyn M. Rojiani(4), Bette K. Kleinschmidt‐DeMasters(4), Arie Perry(4), Suzanne Z. Powell(4), Leslie N. Sutton(4), Daniel J. Silver(3), Brent A. Reynolds(3), David Borchelt(3), Mónica Báñez-Coronel(3), Fatma Ayhan(3), Ronald G. Quisling(3), Terence R. Flotte(3), Bruce C. Trapnell(3), Margaret Humphries(3), Roberto Calcedo(3), Farshid N. Rouhani(3)